Simulations Plus Initiated at Overweight by Stephens & Co.
Simulations Plus Analyst Ratings
Stephens Initiates Simulations Plus(SLP.US) With Buy Rating, Announces Target Price $39
BTIG Maintains Simulations Plus(SLP.US) With Buy Rating, Cuts Target Price to $50
Simulations Plus Analyst Ratings
BTIG Maintains Buy on Simulations Plus, Lowers Price Target to $50
Craig-Hallum Maintains Simulations Plus(SLP.US) With Buy Rating, Announces Target Price $56
JMP Securities Maintains Simulations Plus(SLP.US) With Hold Rating
JMP Securities Reaffirms Their Hold Rating on Simulations Plus (SLP)
Craig-Hallum Maintains Simulations Plus(SLP.US) With Buy Rating
Craig-Hallum Maintains Simulations Plus(SLP.US) With Buy Rating
Craig-Hallum Maintains Simulations Plus(SLP.US) With Buy Rating
Craig-Hallum Maintains Simulations Plus(SLP.US) With Buy Rating
Craig-Hallum Maintains Simulations Plus(SLP.US) With Buy Rating
Craig-Hallum Maintains Simulations Plus(SLP.US) With Buy Rating
Analysts Are Bullish on These Healthcare Stocks: Simulations Plus (SLP), Diamedica Therapeutics (DMAC)
Simulations Plus Analyst Ratings
Oppenheimer Maintains Simulations Plus(SLP.US) With Buy Rating, Maintains Target Price $65
Simulations Plus (SLP) Receives a Buy From Oppenheimer
Simulations Plus Analyst Ratings